Trial
NCT07116499
A Study of K-645 in the Treatment of Multiple Migraine Attacks
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Kallyope Inc.
Collaborators
—
Condition
Acute Migraine
Intervention
Placebo
Why stopped
Study stopped for futility based on an interim analysis of efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-25